Leukemia & Lymphoma, Volume 58, Issue 12 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 58, Issue 12 (2017)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Volume 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary

Cart before the horse: use of Aspergillus PCR to increase the diagnostic yield from BAL in hematological patients at risk of invasive aspergillosis
Olivia Catherine Smibert & Monica A. Slavin
Pages: 2773-2776
Published online: 02 Jun 2017
First Page PreviewforCart before the horse: use of Aspergillus PCR to increase the diagnostic yield from BAL in hematological patients at risk of invasive aspergillosis | Full Text | References | PDF (493.5 KB) | Supplemental
  • 1043 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Reviews

Use of minimal residual disease assessment in the treatment of chronic lymphocytic leukemia
Carolyn Owen, Anna Christofides, Nathalie Johnson, Tatiana Lawrence, David MacDonald & Carol Ward
Pages: 2777-2785
Published online: 16 May 2017
AbstractforUse of minimal residual disease assessment in the treatment of chronic lymphocytic leukemia | Full Text | References | PDF (870 KB) | Supplemental
  • 786 Views
  • 12 CrossRef citations
  • 0Altmetric
Essential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discovery
Sarah Chuzi & Brady L. Stein
Pages: 2786-2798
Published online: 15 May 2017
AbstractforEssential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discovery | Full Text | References | PDF (1 MB) | Supplemental
  • 1645 Views
  • 12 CrossRef citations
  • 0Altmetric
Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome
Naranie Shanmuganathan, Devendra Keshaorao Hiwase & David Morrall Ross
Pages: 2799-2810
Published online: 09 May 2017
AbstractforTreatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome | Full Text | References | PDF (1.2 MB) | Supplemental
  • 952 Views
  • 12 CrossRef citations
  • 0Altmetric
Practical recommendations for the choice of anticoagulants in the management of patients with atrial fibrillation on ibrutinib
Khai Li Chai, Gail Rowan, John F. Seymour, Kate Burbury, Dennis Carney & Constantine S. Tam
Pages: 2811-2814
Published online: 15 May 2017
AbstractforPractical recommendations for the choice of anticoagulants in the management of patients with atrial fibrillation on ibrutinib | Full Text | References | PDF (383.1 KB) | Supplemental
  • 1962 Views
  • 32 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study
Henrik Cederleuf, Lasse Hjort Jakobsen, Fredrik Ellin, Peter de Nully Brown, Thomas Stauffer Larsen, Martin Bøgsted, Thomas Relander, Mats Jerkeman & Tarec Christoffer El-Galaly
Pages: 2815-2823
Published online: 20 Mar 2017
AbstractforOutcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study | Full Text | References | PDF (1.3 MB) | Supplemental
  • 517 Views
  • 19 CrossRef citations
  • 0Altmetric
Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus
Georg Hess, Simon Rule, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Dolores Caballero, Cristina Joao, Mathias Witzens-Harig, Isabelle Bence-Bruckler, Seok-Goo Cho, Wenjiong Zhou, Jenna D. Goldberg, Cristina Trambitas, Christopher Enny, Jessica Vermeulen, Shana Traina, Chiun-Fang Chiou, Joris Diels & Martin Dreyling
Pages: 2824-2832
Published online: 30 May 2017
AbstractforHealth-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus | Full Text | References | PDF (1,009.4 KB) | Supplemental
  • 1055 Views
  • 14 CrossRef citations
  • 0Altmetric
Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma
Jennifer C. Ho, Bouthaina S. Dabaja, Sarah A. Milgrom, Grace L. Smith, Jay P. Reddy, Ali Mazloom, Ken H. Young, Lijuan Deng, L. Jeffrey Medeiros, Wenli Dong, Pamela K. Allen, Therese Y. Andraos, Nathan H. Fowler, Loretta J. Nastoupil, Yasuhiro Oki, Luis E. Fayad, Francesco Turturro, Sattva S. Neelapu, Jason Westin, Fredrick B. Hagemeister, Maria Alma Rodriguez & Chelsea C. Pinnix
Pages: 2833-2844
Published online: 09 May 2017
AbstractforRadiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma | Full Text | References | PDF (1.7 MB) | Supplemental
  • 517 Views
  • 12 CrossRef citations
  • 0Altmetric
Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphoma
Hirokazu Nagai, Takeshi Shimomura, Makoto Takeuchi, Shuichi Hanada, Takuya Komeno, Kazutaka Sunami, Michihiro Hidaka, Takahiro Yano, Kiyoshi Kitano, Isao Yoshida, Nobumasa Inoue, Akiko Saito, Keizo Horibe, Suzuko Motitani, Shu Ichihara, Tomoyuki Watanabe & Morio Sawamura
Pages: 2845-2851
Published online: 16 May 2017
AbstractforPhase II study of intensified rituximab induction and maintenance for low grade B cell lymphoma | Full Text | References | PDF (742.2 KB) | Supplemental
  • 224 Views
  • 0 CrossRef citations
  • 0Altmetric
Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes
Erica S. Herc, Carol A. Kauffman, Bernard L. Marini, Anthony J. Perissinotti & Marisa H. Miceli
Pages: 2852-2858
Published online: 12 Apr 2017
AbstractforDaptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes | Full Text | References | PDF (579.2 KB) | Supplemental
  • 448 Views
  • 17 CrossRef citations
  • 0Altmetric
SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy
Alessandro Busca, Federica Lessi, Luisa Verga, Anna Candoni, Chiara Cattaneo, Simone Cesaro, Giulia Dragonetti, Mario Delia, Alessio De Luca, Gaspare Guglielmi, Mario Tumbarello, Giordana Martino, Gianpaolo Nadali, Rosa Fanci, Marco Picardi, Leonardo Potenza, Annamaria Nosari, Franco Aversa, Livio Pagano & on the behalf of the SEIFEM Group (Sorveglianza Epidemiologica Infezioni Fungine in Emopatie Maligne)
Pages: 2859-2864
Published online: 16 May 2017
AbstractforSEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy | Full Text | References | PDF (564.5 KB) | Supplemental
  • 361 Views
  • 3 CrossRef citations
  • 0Altmetric
Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia
Bozena Büttner, Holger Knoth, Michael Kramer, Reinhard Oertel, Andreas Seeling, Katja Sockel, Malte von Bonin, Friedrich Stölzel, Nael Alakel, Uwe Platzbecker, Christoph Röllig, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig & Jan Moritz Middeke
Pages: 2865-2874
Published online: 16 May 2017
AbstractforImpact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia | Full Text | References | PDF (1.5 MB) | Supplemental
  • 246 Views
  • 6 CrossRef citations
  • 0Altmetric
Eosinophil-rich tissue infiltrates in chronic myelomonocytic leukemia patients
Nathalie Droin, Nolwenn Lucas, Vincent Parinet, Dorothée Selimoglu-Buet, Marc Humbert, Véronique Saada, Olivier Lambotte, Eric Solary & Nicolas Noël
Pages: 2875-2879
Published online: 08 Jun 2017
AbstractforEosinophil-rich tissue infiltrates in chronic myelomonocytic leukemia patients | Full Text | References | PDF (745.6 KB) | Supplemental
  • 214 Views
  • 2 CrossRef citations
  • 0Altmetric

Original Articles: Research

Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment
Juan Eduardo Megías-Vericat, Pau Montesinos, María José Herrero, Federico Moscardó, Virginia Bosó, David Martínez-Cuadrón, Luis Rojas, Rebeca Rodríguez-Veiga, Blanca Boluda, Luis Sendra, José Cervera, José Luis Poveda, Miguel Ángel Sanz & Salvador F. Aliño
Pages: 2880-2894
Published online: 02 Jun 2017
AbstractforInfluence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment | Full Text | References | PDF (1.3 MB) | Supplemental
  • 626 Views
  • 12 CrossRef citations
  • 0Altmetric
MEF2C-dysregulated pediatric T-cell acute lymphoblastic leukemia is associated with CDKN1B deletions and a poor response to glucocorticoid therapy
Sara Colomer-Lahiguera, Markus Pisecker, Margit König, Karin Nebral, Winfried F. Pickl, Maximilian O. Kauer, Oskar A. Haas, Reinhard Ullmann, Andishe Attarbaschi, Michael N. Dworzak & Sabine Strehl
Pages: 2895-2904
Published online: 09 May 2017
AbstractforMEF2C-dysregulated pediatric T-cell acute lymphoblastic leukemia is associated with CDKN1B deletions and a poor response to glucocorticoid therapy | Full Text | References | PDF (1.6 MB) | Supplemental
  • 449 Views
  • 15 CrossRef citations
  • 0Altmetric
Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cells
Sergey A. Dyshlovoy, Stefanie Rast, Jessica Hauschild, Katharina Otte, Winfried H. Alsdorf, Ramin Madanchi, Vladimir I. Kalinin, Alexandra S. Silchenko, Sergey A. Avilov, Judith Dierlamm, Friedemann Honecker, Valentin A. Stonik, Carsten Bokemeyer & Gunhild von Amsberg
Pages: 2905-2915
Published online: 16 May 2017
AbstractforFrondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cells | Full Text | References | PDF (2.3 MB) | Supplemental
  • 229 Views
  • 22 CrossRef citations
  • 0Altmetric
Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance
Barbara Muz, Hubert D. Kusdono, Feda Azab, Pilar de la Puente, Cinzia Federico, Mark Fiala, Ravi Vij, Noha N. Salama & Abdel Kareem Azab
Pages: 2916-2925
Published online: 16 May 2017
AbstractforTariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance | Full Text | References | PDF (1.2 MB) | Supplemental
  • 395 Views
  • 23 CrossRef citations
  • 0Altmetric
Cytotoxic T cells in chronic idiopathic neutropenia express restricted antigen receptors
Semeli Mastrodemou, Evangelia Stalika, Anna Vardi, Katerina Gemenetzi, Michalis Spanoudakis, Maria Karypidou, Irene Mavroudi, Anastasia Hadzidimitriou, Catherine Stavropoulos-Giokas, Helen A. Papadaki & Kostas Stamatopoulos
Pages: 2926-2933
Published online: 23 May 2017
AbstractforCytotoxic T cells in chronic idiopathic neutropenia express restricted antigen receptors | Full Text | References | PDF (898.9 KB) | Supplemental
  • 187 Views
  • 6 CrossRef citations
  • 0Altmetric
Advanced glycation endproducts (AGEs) in saliva of patients with multiple myeloma – a pilot study
Joseph Katz, Jan Moreb, Catherine Baitinger, Christine Singer & Robert M. Caudle
Pages: 2934-2938
Published online: 06 Jul 2017
AbstractforAdvanced glycation endproducts (AGEs) in saliva of patients with multiple myeloma – a pilot study | Full Text | References | PDF (510.4 KB) | Supplemental
  • 246 Views
  • 7 CrossRef citations
  • 0Altmetric
High frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064)
Nina D. Wagner-Johnston, Shelly Lensing, Ariela Noy, Lee Ratner, David Henry, Jeannette Y. Lee, Sylvia Silver, Malek Faham & Richard F. Ambinder
Pages: 2939-2942
Published online: 16 May 2017
AbstractforHigh frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064) | Full Text | References | PDF (428.6 KB) | Supplemental
  • 203 Views
  • 2 CrossRef citations
  • 0Altmetric

Letters to the Editor

The predictive value of Aspergillus PCR testing on bronchoalveolar lavage fluid for early diagnosis of invasive pulmonary aspergillosis in hematologic patients
Francesco Marchesi, Antonio Spadea, Fulvia Pimpinelli, Grazia Prignano, Maria Grazia Paglia, Daniele Forcella, Svitlana Gumenyuk, Daniela Renzi, Francesca Palombi, Antonella Vulcano, Francesco Pisani, Atelda Romano, Elena Papa, Francesco Facciolo, Fabrizio Ensoli, Corrado Girmenia & Andrea Mengarelli
Pages: 2943-2946
Published online: 09 May 2017
First Page PreviewforThe predictive value of Aspergillus PCR testing on bronchoalveolar lavage fluid for early diagnosis of invasive pulmonary aspergillosis in hematologic patients | Full Text | References | PDF (389.8 KB) | Supplemental
  • 231 Views
  • 6 CrossRef citations
  • 0Altmetric
G-CSF improves safety when you start the day after autologous transplant in multiple myeloma
Douglas W. Sborov, Yu Kyoung Cho, Francesca Cottini, Erinn M. Hade, Misty Lamprecht, Karen Tackett, Nidhi Sharma, Nita Williams, Junan Li, Steven Devine, Ming Poi, Mitch A. Phelps & Craig C. Hofmeister
Pages: 2947-2951
Published online: 16 May 2017
First Page PreviewforG-CSF improves safety when you start the day after autologous transplant in multiple myeloma | Full Text | References | PDF (778.7 KB) | Supplemental
  • 292 Views
  • 2 CrossRef citations
  • 0Altmetric
Second cancers in survivors of plasmacytoma of bone in the U.S.A: a SEER database analysis
Mohamed Abd El-Fattah
Pages: 2952-2956
Published online: 12 Apr 2017
First Page PreviewforSecond cancers in survivors of plasmacytoma of bone in the U.S.A: a SEER database analysis | Full Text | References | PDF (991.2 KB) | Supplemental
  • 139 Views
  • 0 CrossRef citations
  • 0Altmetric
Haploidentical hematopoietic stem cell transplantation with myeloablative conditioning regimen could serve as an optional salvage therapy for younger patients with refractory or relapsed aggressive non-Hodgkin lymphoma
Xiaofang Xiao, Haiwen Huang, Jia Chen, Yibin Jiang, Lihong Zhang, Yang Xu, Ting Xu, Xiaochen Chen, Caixia Li, Zhengming Jin, Jia Ruan & Depei Wu
Pages: 2957-2961
Published online: 16 May 2017
First Page PreviewforHaploidentical hematopoietic stem cell transplantation with myeloablative conditioning regimen could serve as an optional salvage therapy for younger patients with refractory or relapsed aggressive non-Hodgkin lymphoma | Full Text | References | PDF (787.3 KB) | Supplemental
  • 186 Views
  • 3 CrossRef citations
  • 0Altmetric
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance
Hani Hassoun, Mikhail Roshal, Joshua Sabari, James Nguyen, Qi Gao, Sean M. Devlin, Heather Landau, Nikoletta Lendvai, David J. Chung, Alexander M. Lesokhin, Neha Korde, Sham Mailankody, Ahmet Dogan, Sergio A. Giralt & C. Ola Landgren
Pages: 2962-2965
Published online: 09 May 2017
First Page PreviewforImmunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance | Full Text | References | PDF (1.2 MB) | Supplemental
  • 534 Views
  • 4 CrossRef citations
  • 0Altmetric
Is HBV prophylaxis required during CLL treatment with ibrutinib?
Alessandra Tedeschi, Anna Maria Frustaci, Maddalena Mazzucchelli, Roberto Cairoli & Marco Montillo
Pages: 2966-2968
Published online: 23 May 2017
First Page PreviewforIs HBV prophylaxis required during CLL treatment with ibrutinib? | Full Text | References | PDF (313.1 KB) | Supplemental
  • 548 Views
  • 11 CrossRef citations
  • 0Altmetric
Identification of a novel fusion TBL1XR1–PDGFRB in a patient with acute myeloid leukemia harboring the DEK–NUP214 fusion and clinical response to dasatinib
Paulo Vidal Campregher, Nathalia da Silva Halley, Gabriela Amaral Vieira, Juliana Folloni Fernandes, Elvira Deolinda Rodrigues Pereira Velloso, Siraj Ali, Tariq Mughal, Vincent Miller, Cristovão Luis Pitangueira Mangueira, Vicente Odone & Nelson Hamerschlak
Pages: 2969-2972
Published online: 16 May 2017
First Page PreviewforIdentification of a novel fusion TBL1XR1–PDGFRB in a patient with acute myeloid leukemia harboring the DEK–NUP214 fusion and clinical response to dasatinib | Full Text | References | PDF (1.3 MB) | Supplemental
  • 456 Views
  • 12 CrossRef citations
  • 0Altmetric
Long-term persistent donor–recipient mixed chimerism without disease recurrence after myeloablative single-unit cord blood transplantation in adult acute myeloid leukemia following myelodysplastic syndrome
Susumu Tanoue, Takaaki Konuma, Satoshi Takahashi, Eri Watanabe, Natsuko Sato, Nobukazu Watanabe, Masamichi Isobe, Seiko Kato, Jun Ooi & Arinobu Tojo
Pages: 2973-2975
Published online: 16 May 2017
First Page PreviewforLong-term persistent donor–recipient mixed chimerism without disease recurrence after myeloablative single-unit cord blood transplantation in adult acute myeloid leukemia following myelodysplastic syndrome | Full Text | References | PDF (401 KB) | Supplemental
  • 200 Views
  • 1 CrossRef citations
  • 0Altmetric
Are chronic myeloid leukemia patients ready to stop long-term treatment?
Massimo Breccia & Fabio Efficace
Pages: 2976-2978
Published online: 23 May 2017
First Page PreviewforAre chronic myeloid leukemia patients ready to stop long-term treatment? | Full Text | References | PDF (308.7 KB) | Supplemental
  • 148 Views
  • 2 CrossRef citations
  • 0Altmetric
No adverse effect of granulocyte colony-stimulating factor during the peri-implantation period of an unrecognized pregnancy in a donor of peripheral blood stem cells
Lucile Debus, Stéphane Vigouroux, Guillaume Gargallo, Fabienne Adiko & Noël Milpied
Pages: 2979-2980
Published online: 09 May 2017
CitationforNo adverse effect of granulocyte colony-stimulating factor during the peri-implantation period of an unrecognized pregnancy in a donor of peripheral blood stem cells | Full Text | References | PDF (252.8 KB) | Supplemental
  • 97 Views
  • 2 CrossRef citations
  • 0Altmetric
Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis
Marine Baron, Jean Marc Zini, Thibaut Challan Belval, Marguerite Vignon, Blandine Denis, Alexandre Alanio & Marion Malphettes
Pages: 2981-2982
Published online: 30 May 2017
CitationforFungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis | Full Text | References | PDF (261.6 KB) | Supplemental
  • 573 Views
  • 47 CrossRef citations
  • 0Altmetric
Low-dose splenic irradiation prior to hematopoietic cell transplantation in hypersplenic patients with myelofibrosis
Noah S. Kalman, Nitai D. Mukhopadhyay, Catherine H. Roberts, Harold M. Chung, William B. Clark, John M. McCarty, Amir A. Toor & Shiyu Song
Pages: 2983-2984
Published online: 31 May 2017
CitationforLow-dose splenic irradiation prior to hematopoietic cell transplantation in hypersplenic patients with myelofibrosis | Full Text | References | PDF (360.9 KB) | Supplemental
  • 355 Views
  • 12 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Outcomes of patients aged ≥26 years with relapsed or refractory B-cell acute lymphoblastic leukemia in ZUMA-3 and historical trials
Monique C. Minnema et al.
Article | Published online: 24 May 2024
Open Access
Acceleration of non-Hodgkin lymphoma progression during pregnancy in a murine model
Netanel A. Horowitz et al.
Letter to the Editor | Published online: 23 May 2024
Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B, high TCL1A expression, or over- expressed MYC/BCL-2
Yang Liu et al.
Article | Published online: 22 May 2024
Open Access
Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia
Karolina Bełdzińska-Gądek et al.
Article | Published online: 22 May 2024
View all latest articles